230 related articles for article (PubMed ID: 2973777)
21. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
Holubarsch C; Pieske B; Hasenfuss G; Just H
Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
[TBL] [Abstract][Full Text] [Related]
22. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
23. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
[TBL] [Abstract][Full Text] [Related]
24. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
[TBL] [Abstract][Full Text] [Related]
25. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
[TBL] [Abstract][Full Text] [Related]
26. [Arrhythmia in patients with low cardiac output after valvular surgery. Randomized, double-blind comparative study of dobutamine versus enoximone].
Atallah G; George M; Lehot JJ; Bastien O; Bejuit R; Durand PG; Estanove S
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():63-8. PubMed ID: 2147837
[TBL] [Abstract][Full Text] [Related]
27. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
[TBL] [Abstract][Full Text] [Related]
28. Quantitative assessment of the effects of 'inodilators' on the myocardium in patients without primary cardiac insufficiency after coronary surgery: Part II--Enoximone.
Redmann K; Lunkenheimer PP; Isringhaus H; Geiger A; Rettig G; Flameng W; Demeyre T; Engel C; Peterschmidt O
Thorac Cardiovasc Surg; 1991 Jun; 39(3):129-32. PubMed ID: 1831936
[TBL] [Abstract][Full Text] [Related]
29. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
Boesch C; Dubois-Rande JL; Pochmalicki G; Lellouche D; Teiger E; Saal JP; Cachin JC; Mallo C; Castaigne A; Jan F
Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193
[TBL] [Abstract][Full Text] [Related]
30. [Enoximone in the postoperative phase of heart surgery].
Hachenberg T
Z Kardiol; 1994; 83 Suppl 2():63-8. PubMed ID: 8091826
[TBL] [Abstract][Full Text] [Related]
31. [Enoximone as pharmacologic "bridging" to heart transplantation].
Friedel N; Teebken M; Lemme A; Schüler S; Hetzer R
Z Kardiol; 1991; 80 Suppl 4():27-33. PubMed ID: 1833894
[TBL] [Abstract][Full Text] [Related]
32. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
33. [Acute effect of enoximone and captopril in patients with heart failure].
Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD
Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of direct effects of enoximone on systemic and pulmonary vascular bed in animals with a Jarvik total artificial heart.
Deleuze PH; Rande JL; Okude J; Wan F; Brunet S; Thoraval FR; Cachera JP; Loisance DY
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):589-94. PubMed ID: 1532041
[TBL] [Abstract][Full Text] [Related]
35. [Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
Boldt J; Kling D; Schuhmann E; Dapper F; Hempelmann G
Anaesthesist; 1989 May; 38(5):238-44. PubMed ID: 2525351
[TBL] [Abstract][Full Text] [Related]
36. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
37. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
38. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery.
Tarr TJ; Moore NA; Frazer RS; Shearer ES; Desmond MJ
Eur J Anaesthesiol Suppl; 1993; 8():15-24. PubMed ID: 8223351
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic activity of different doses of sulmazole by infusion.
Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]